These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15870670)

  • 1. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
    Brodtman DH; Rosenthal DW; Redner A; Lanzkowsky P; Bonagura VR
    J Pediatr; 2005 May; 146(5):654-61. PubMed ID: 15870670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revaccination of children after completion of standard chemotherapy for acute leukemia.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
    Zengin E; Sarper N
    Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
    Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
    Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
    Holownia A; Trofimiuk E; Krawczuk-Rybak M; Jakubow P; Kaliszewski J; Muszynska-Roslan K; Braszko JJ
    Acta Haematol; 2004; 112(4):222-4. PubMed ID: 15564737
    [No Abstract]   [Full Text] [Related]  

  • 9. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.
    Kosmidis S; Baka M; Bouhoutsou D; Doganis D; Kallergi C; Douladiris N; Pourtsidis A; Varvoutsi M; Saxoni-Papageorgiou F; Vasilatou-Kosmidis H
    Pediatr Blood Cancer; 2008 Mar; 50(3):528-32. PubMed ID: 17853465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Kager L; Lion T; Attarbaschi A; Koenig M; Strehl S; Haas OA; Dworzak MN; Schrappe M; Gadner H; Mann G;
    Haematologica; 2007 Nov; 92(11):1561-4. PubMed ID: 18024406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia.
    Bakhshi S; Sethuraman G; Singh MK; Arya LS
    Pediatr Dermatol; 2005; 22(6):543-5. PubMed ID: 16354258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
    Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
    Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
    Lauten M; Güttel C; Härtel C; Erdlenbruch B
    Klin Padiatr; 2014 May; 226(3):188-9. PubMed ID: 24158893
    [No Abstract]   [Full Text] [Related]  

  • 14. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
    Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute pancreatitis during chemotherapy of acute lymphoblastic leukaemia complicated with pseudocyst].
    Sikorska-Fic B; Stańczak E; Matysiak M; Kamiński A
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1051-5. PubMed ID: 19531825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
    Nowak-Göttl U; Ahlke E; Fleischhack G; Schwabe D; Schobess R; Schumann C; Junker R
    Blood; 2003 Apr; 101(7):2529-33. PubMed ID: 12517808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
    Malhotra P; Kapoor G; Jain S; Garg B
    Indian Pediatr; 2018 Oct; 55(10):877-879. PubMed ID: 29941701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
    Kaya Z; Gursel T; Bakkaloglu SA; Kocak U; Atasever T; Oktar SO
    Pediatr Hematol Oncol; 2007 Jun; 24(4):257-67. PubMed ID: 17613868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
    J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol].
    Janić D; Dokmanović L; Jovanović N; Skorić D; Lazić J
    Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():17-22. PubMed ID: 15615459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.